BiondVax Pharmaceuticals ltd.

Quick facts

Phase 3 pipeline

• M-001 · Immunology / Infectious Disease
  M-001 is a multivalent recombinant influenza vaccine designed to stimulate broad immune responses against multiple influenza strains.

Phase 2 pipeline

• Adjuvanted PBS · Immunology / Infectious Disease
  Adjuvanted PBS is a polyepitope peptide-based vaccine that stimulates broad immune responses against multiple influenza strains by combining conserved viral peptides with an adjuvant.
• PBS and TIV 15%
• PBS and TIV 50%

Phase 1 pipeline

• Adjuvant: Montonide isa 51 VG
• Adjuvanted Multimeric-001 250mcg

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• BiondVax Pharmaceuticals ltd. portfolio CI brief
• BiondVax Pharmaceuticals ltd. pipeline updates RSS